|Articles|May 1, 2019
- BioPharm International-05-01-2019
- Volume 32
- Issue 5
BioPharm International, May 2019 Issue (PDF)
Click the title above to open the BioPharm International May 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Optimizing Diaphragm Valves to Improve Bioprocess Reliabilityalmost 7 years ago
What’s New in Upstream Technologiesalmost 7 years ago
FDA Faces Challenges After Gottliebalmost 7 years ago
Bioprocessing Facilities and FDA Inspection Problemsalmost 7 years ago
The Auditor Vs. Inspector Issuealmost 7 years ago
New Kit Identifies Endonuclease Impuritiesalmost 7 years ago
Multichannel Pipettes for 384-Well Platesalmost 7 years ago
Challenges with Successful Commercialization of Biosimilarsalmost 7 years ago
Single-Use for Downstream Chromatography: Benefit or Hindrance?Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
